Gene: FAM118A
Official Full Name: family with sequence similarity 118 member Aprovided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17812 | FAM118A Knockout cell line (HeLa) | Human | FAM118A | 1:3~1:6 | Negative | Online Inquiry |
KO17813 | FAM118A Knockout cell line (HCT 116) | Human | FAM118A | 1:2~1:4 | Negative | Online Inquiry |
KO17814 | FAM118A Knockout cell line (HEK293) | Human | FAM118A | 1:3~1:6 | Negative | Online Inquiry |
KO17815 | FAM118A Knockout cell line (A549) | Human | FAM118A | 1:3~1:4 | Negative | Online Inquiry |
FAM118A Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate in-depth studies of the FAM118A gene's biological functions. Utilizing CRISPR-Cas9 technology, these cell lines demonstrate a complete disruption of the FAM118A gene, permitting researchers to investigate its role in cellular processes, disease mechanisms, and potential therapeutic targets. The knockout model allows for the elimination of FAM118A expression, enabling studies on the downstream effects on cellular signaling pathways, gene expression profiles, and tissue-specific functionalities.
The key function of FAM118A gene knockout cell lines lies in their ability to elucidate the gene's involvement in critical biological processes such as cell proliferation, differentiation, and apoptosis. Researchers harness these cell lines to explore the gene's involvement in diseases, particularly its linkage to cancer progression and cellular response to stress conditions. This cell model serves as an invaluable tool for evaluating novel therapeutic compounds and understanding drug resistance mechanisms in targeted therapies.
In both research and clinical settings, FAM118A Gene Knockout Cell Lines offer significant advantages over traditional models. They provide a precise and reproducible system, reduce genetic variability, and promote reliable data collection, ultimately leading to enhanced translational outcomes. Furthermore, their ease of use in standard laboratory protocols and compatibility with high-throughput screening approaches streamline experimental workflows.
The value of FAM118A Gene Knockout Cell Lines to researchers and clinicians is underscored by the urgent need for innovative methods to dissect complex gene functions within pathological contexts. These cell lines serve as a cornerstone for the development of personalized medicine strategies, aiding the identification of patient subgroups that may benefit from specific therapies.
Our company specializes in producing high-quality, validated genetic models that empower researchers with the tools necessary for advanced biological inquiry. With a commitment to innovation and excellence, our offerings support the diverse needs of the scientific community, paving the way for breakthroughs in medical research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.